Key result
Lower heart rate variability linked to rapid CKD progression in non-dialysis patients.
Why the study?
Autonomic dysfunction evaluated by heart rate variability may have prognostic significance on renal function decline in non-dialysis chronic kidney disease patients.
Does heart rate variability predict rapid renal function deterioration in non-dialysis chronic kidney disease patients?
Observational (n=326)
Does heart rate variability predict rapid renal function deterioration in non-dialysis chronic kidney disease patients?
Reduced heart rate variability, specifically lower lnLF/HF, is an independent predictor of rapid renal function deterioration in patients with non-dialysis chronic kidney disease.
Aim Autonomic dysfunction contributes to cardiovascular morbidity/mortality and can be evaluated with heart rate variability (HRV). This study is to evaluate the prognostic significance of HRV on renal function in non‐dialysis chronic kidney disease (CKD) patients. Methods We enrolled 326 non‐dialysis CKD patients in this prospective observational study. The median follow‐up period was 2.02 years. Five‐minutes of electrocardiography recordings obtained at enrolment were reprocessed to assess HRV. Five frequency‐domain measures and one time‐domain measures were obtained. Rapid CKD progression was defined as annual estimated glomerular filtration rate (eGFR) loss over 30% per year or eGFR decline rate over 3 mL/min per 1.73 m2 per year. The prevalence of abnormal HRV, associated factors of HRV and impact of HRV on the risk of CKD progression were analyzed. Results The abnormality of HRV increased along with the severity of CKD. In patients with stage 5 CKD, the proportion of abnormal ln(low frequency power) (LF), ln(high frequency power) (HF), lnLF/HF were 69.5, 52.8 and 50%, respectively. Associated factors of HRV included advanced CKD, diabetes mellitus, serum albumin, severe proteinuria, Beck Anxiety Inventory score, erythropoietin use, renin‐angiotensin system inhibitors and heart failure. Multivariate logistic regression model analysis revealed lower lnLF/HF, hypertension and severe proteinuria were the risk factors of rapid CKD progression. Conclusion The prevalence of autonomic dysfunction measured by HRV among each stage CKD patients is different. Most patients in advanced CKD stage have reduced values of HRV parameters. The estimation of lnLF/HF also provided prognostic information on CKD progression in addition to classical risk factors.
No takes yet. Share an insight, caveat, or question.
Chou et al. (2018) conducted an observational in non-dialysis chronic kidney disease (n=326). Heart rate variability (lower lnLF/HF) was evaluated on Rapid CKD progression (annual eGFR loss over 30% per year or eGFR decline rate over 3 mL/min per 1.73 m2 per year). Lower lnLF/HF, a measure of heart rate variability, was identified as a risk factor for rapid disease progression in non-dialysis chronic kidney disease patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: